Ambulatory Care Quality Improvement (ACQUIP)

Status Completed

Clinical Trial Summary

Health care organizations, including the VA, are investing substantial effort to improve quality of care. As part of this process, greater emphasis is being placed on measurement of outcomes, and in particular, functional outcomes and satisfaction as reported by patients.

Clinical Trial Description

Background:

Health care organizations, including the VA, are investing substantial effort to improve quality of care. As part of this process, greater emphasis is being placed on measurement of outcomes, and in particular, functional outcomes and satisfaction as reported by patients.

Objectives:

ACQUIP was designed to determine whether quality and outcomes of health care improve when primary care providers have access to regular assessments of their patients' health and function along with routine clinical data and information about clinical guidelines.

Methods:

This study was a randomized trial conducted at the General Internal Medicine Clinics of seven VA facilities. Each participating GIMC is organized into discrete firms staffed by different groups of providers who care for different patients. One randomly selected firm received the intervention and one served as control. Patients who made at least one GIMC visit in the last year were eligible to participate. Patients were surveyed at baseline to determine active medical problems. Subsequent mailings included a general evaluation of health status (SF-36), a satisfaction questionnaire and, as appropriate, one of six condition-specific questionnaires: the Seattle Angina Questionnaire, the Seattle Obstructive Lung Disease Questionnaire, the Hopkins Symptom Checklist (depression), and questionnaires regarding diabetes, drinking, and hypertension. Clinical/utilization data were downloaded weekly from VISTA and supplemented with data from Austin. The intervention consisted of multi-faceted reports to patients' primary care providers (at the time of patient visits) showing trended physiologic and health status data and guideline-derived recommendations. Clinicians also received periodical reports displaying trends in the health status and satisfaction of their patients compared with their clinic as a whole. Reports were supplemented by training on QI and health status measures.

Status:

Data collection was completed on April 1, 2000. Analysis of trial results will be completed January, 2001. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00013130
Study type	Interventional
Source	VA Office of Research and Development
Contact
Status	Completed
Phase	Phase 2
Completion date	February 2001

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05563662` - SURgical Registry of ENDocarditis EuRope
Completed	`NCT03444116` - Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy
Recruiting	`NCT04715581` - Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty	N/A
Recruiting	`NCT05595200` - Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
Recruiting	`NCT05360212` - Anatomy-based Fitting in Cochear Implant Users	N/A
Terminated	`NCT05379452` - Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in Shanghai
Completed	`NCT01176110` - Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement	N/A
Terminated	`NCT02167685` - The Chimerix CMX001 Registry
Recruiting	`NCT05506293` - European Multicentre Registry of Percutaneous Paravalvular Leak Closure
Recruiting	`NCT03711526` - Prognostic Value of Preoperative 6-Minute Walk Test for Laparoscopic Gastrointestinal Surgery
Recruiting	`NCT03123536` - Use of Point-of-care Ultrasound in High Risk Surgical Patients	N/A
Recruiting	`NCT05551923` - Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral Hemorrhage
Recruiting	`NCT05494632` - Interaural Mismatch in SSD CI Users	N/A
Completed	`NCT03736304` - The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients	N/A
Completed	`NCT03354546` - Development and Validation of a Preoperative Frailty Index Using Health Administrative Data	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.